Reduction of infarct size with D-myo-inositol trisphosphate: Role of PI3-kinase and mitochondrial KATP channels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 2, 2006, Pages

  Przyklenk, Karin ^a   Maynard, Michelle ^a   Whittaker, Peter ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Myocardial infarction; Myocardial ischemia; Preconditioning; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; BUFFER; CHELERYTHRINE; CLAMIKALANT; INOSITOL TRISPHOSPHATE; ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROTEIN KINASE B; PROTEIN KINASE C; TETRAZOLIUM; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 5-HYDROXYDECANOIC ACID; ALKALOID; BENZAMIDE DERIVATIVE; BENZOPHENANTHRIDINE DERIVATIVE; CARDIOTONIC AGENT; CHROMONE DERIVATIVE; DECANOIC ACID DERIVATIVE; ENZYME INHIBITOR; HYDROXYACID; INOSITOL 1,4,5 TRISPHOSPHATE; MITOCHONDRIAL K(ATP) CHANNEL; MORPHOLINE DERIVATIVE; PHENANTHRIDINE DERIVATIVE; PROTEIN KINASE C EPSILON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SARCOLEMMA; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE; IN VITRO STUDY; METABOLISM; PATHOLOGY; STEREOISOMERISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALKALOIDS; ANIMALS; BENZAMIDES; BENZOPHENANTHRIDINES; CARDIOTONIC AGENTS; CHROMONES; DECANOIC ACIDS; ENZYME INHIBITORS; HYDROXY ACIDS; INOSITOL 1,4,5-TRISPHOSPHATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MORPHOLINES; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENANTHRIDINES; POTASSIUM CHANNELS; PROTEIN KINASE C-EPSILON; RABBITS; STEREOISOMERISM;

EID: 33644862832     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00799.2005     Document Type: Article

References (32)

1. 3 signaling pathway in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 288: H83-H88, 2005.
2. Bauer B, Simkhovich BZ, Kloner RA, and Przyklenk K. Preconditioning- induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart. Basic Res Cardiol 94: 31-40, 1999.
3. Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32: 235-249, 2002.
4. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
5. Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, and Warltier DC. Cardioprotection by volatile anesthetics. Vascul Pharmacol 42: 243-252, 2005.
6. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, and Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK 1/2. Am J Physiol Heart Circ Physiol 289: H1618-H1626, 2005.
7. Downey JM and Cohen MV. We think we see a pattern emerging here. Circulation 111: 120-121, 2005.
8. Eckmann L, Rudolf MT, Ptasznik A, Schultz C, Jiang T, Wolfson N, Tsien R, Fierer J, Shears SB, Kagnoff MF, and Traynor-Kaplan AE D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways. Proc Natl Acad Sci USA 94: 14456-14460, 1997.
9. Gross GJ and Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285: H921-H930, 2003.
10. 3 signaling mimics preconditioning in rabbit heart. Am J Physiol Heart Circ Physiol 277: H2458-H2469, 1999.
11. Hausenloy DJ, Tsang A, Mocanu MM, and Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288: H971-H976, 2005.
12. Kohro S, Hogan QH, Warltier DC, and Bosnjak ZJ. Protein kinase C inhibitors produce mitochondrial flavoprotein oxidation in cardiac myocytes. Anesth Analg 99: 1316-1322, 2004.
13. Krenz M, Baines CP, Heusch G, Downey JM, and Cohen MV. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol 33: 2015-2022, 2001.
14. Krieg T, Qin Q, Philipp S, Alexeyev MF, Cohen MV, and Downey JM. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol Heart Circ Physiol 287: H2606-H2611, 2004.
15. Le Corvoisier P, Lacotte J, Laplace M, and Crozatier B. Interaction of chelerythrine with inositol phosphate metabolism. Fundam Clin Pharmacol 16: 31-37, 2002.
16. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 94: 7-16, 2004.
17. ATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 283: H440-H447, 2002.
18. + channels and their role in cardioprotection. Circ Res 94: 420-432, 2004.
19. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, and Downey JM. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
20. Penna C, Alloatti G, Cappello S, Gattullo D, Berta G, Mognetti B, Losano G, and Pagliaro P. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 288: H2512-H2520, 2005.
21. Piccolo E, Vignati S, Maffucci T, Innominato PF, Riley AM, Potter BV, Pandolfi PP, Broggini M, Iacobelli S, Innocenti P, and Falasca M. Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway. Oncogene 23: 1754-1765, 2004.
22. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
23. Przyklenk K, Li G, Simkhovich BZ, and Kloner RA. Mechanisms of myocardial ischemic preconditioning are age related: PKC-ε does not play a requisite role in old rabbits. J Appl Physiol 95: 2563-2569, 2003.
24. Przyklenk K, Maynard M, Darling CE, and Whittaker P. Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. J Pharmacol Exp Ther 314: 1386-1392, 2005.
25. Qin Q, Downey JM, and Cohen MV. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol 284: H727-H734, 2003.
26. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, and Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest 101: 2182-2198, 1998.
27. Tong H, Chen W, Steenbergen C, and Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87: 309-315, 2000.
28. Tsuchida A, Miura T, Tanno M, Sakamoto J, Miki T, Kuno A, Matsumoto T, Ohnuma Y, Ichikawa Y, and Shimamoto K. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. J Am Coll Cardiol 40: 1523-1530, 2002.
29. Vermassen E, Parys JB, and Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96: 3-17, 2004.
30. Ward SG, Mills SJ, Liu C, Westwick J, and Potter BV. D-myo-Inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase. J Biol Chem 270: 12075-12084, 1995.
31. Yellon DM and Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83: 1113-1151, 2003.
32. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang XM, Herbert D, Cohen MV, and Downey JM. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol Heart Circ Physiol 267: H2383-H2390, 1994.